-- 
Aegon, EVS Broadcast, KBC, Wereldhave: Benelux Equity Preview

-- B y   J o h n   M a r t e n s   a n d   J u r j e n   v a n   d e   P o l
-- 
2011-05-12T04:01:00Z

-- http://www.bloomberg.com/news/2011-05-11/aegon-evs-broadcast-kbc-wereldhave-benelux-equity-preview.html
The following companies may have
unusual price changes in Benelux markets. Stock symbols are in
parentheses, and prices are from the previous close.  The  AEX-Index (AEX)  in Amsterdam declined 0.1 percent to 360.55.
 Belgium ’s Bel20 Index lost 0.5 percent to 2,719.31. Luxembourg’s
LuxX Index rose 0.1 percent to 1,441.72.  Dutch stocks:  Aegon NV (AGN)  : The insurer may report first-quarter net
income of 337.3 million euros ($479 million), according to the
average estimate of 11 analysts surveyed by Bloomberg. Aegon
rose 1.8 percent to 5.38 euros.  Pharming Group NV (PHARM)  : The drug developer may report
a first-quarter loss excluding some items of 16.4 million euros,
according to the average estimate of five analysts surveyed by
Bloomberg. Pharming fell 2 percent to 15 cents.  Wereldhave NV (WHA)  : The property investor is scheduled
to report first-quarter results before the start of trading.
Wereldhave retreated 0.1 percent to 70.82 euros.  Belgian stocks:  EVS Broadcast Equipment SA (EVS)  : The maker of
television-production equipment is scheduled to report first-
quarter earnings before the start of trading. EVS declined 0.6
percent to 44.80 euros.  KBC Groep NV (KBC)  : Belgium’s biggest bank and insurer
by market value may say first-quarter net income rose to 650.5
million euros, according to the average of eight analyst
estimates compiled by Bloomberg, from 442 million euros a year
earlier. KBC gained 2 percent to 27.91 euros.  Zetes Industries SA (ZTS)  : The maker of Belgium’s
electronic identity cards said first-half earnings before
interest, tax, depreciation and amortization will rise more than
40 percent from a year earlier. Zetes retreated 0.3 percent to
18.50 euros.  To contact the reporters on this story:
John Martens in Brussels at 
 jmartens1@bloomberg.net ;
Jurjen van de Pol in Amsterdam at 
 jvandepol@bloomberg.net   To contact the editors responsible for this story:
Angela Cullen at   acullen8@bloomberg.net ;
Craig Stirling at   cstirling1@bloomberg.net . 